Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma.
Hinz TK, Le AT, Doan T, Ast A, Jaramillo S, Haines S, Navarro A, Patil T, Nemenoff RA, Heasley LE. Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. bioRxiv. 2025 Jun 07.